Atlas Trials

Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis

Clinical trial NCT02063399 · UNKNOWN

Trial details

NCT number
NCT02063399
Sponsor
Chinese University of Hong Kong
Status
UNKNOWN
Study type
OBSERVATIONAL
Nasopharyngeal Carcinoma
Start date
2013-07-01
Primary completion
2016-08-01
Enrollment
20302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.